Jindal, S and Ganopadhyay, K K and Santhosh, R and Donagaon, S and Chopra, V and Paserkar, G and Mohan, V (2019) Efficacy of the Modern SU Glimepiride in Reducing Hyperglycemia in T2DM. Journal of the Association of Physicians of India, 67 . p. 33.
Sulfonylureas (SUs) have been used for several decades for diabetes therapy, but the risk of severe hypoglycemia and weight gain associated with this class of drugs has rendered them a subject of controversy. In this context, modern SUs such as glimepiride have emerged as potentially safe and effective candidates for both monotherapy and combination therapy with other antidiabetic drugs such as metformin. Several clinical studies have validated the beneficial effects of glimepiride. A few such studies have established glimepiride as a relatively more potent antidiabetic drug vs. other SUs. Such studies indicate the potential of glimepiride as a preferred drug in the therapy of people with type 2 diabetes mellitus (T2DM). Here we will discuss the efficacy of glimepiride in reducing hyperglycemia in T2DM.
|Uncontrolled Keywords:||T2DM; Hyperglycemia|
|Subjects:||Diabetology > Diabetes Mellitus Type 2|
|Divisions:||Department of Diabetology|
|Deposited By:||surendar radha|
|Deposited On:||05 Feb 2020 12:36|
|Last Modified:||05 Feb 2020 12:36|
Repository Staff Only: item control page